TLC-144

N/A

Report date: 2024/12/05 16:47:16

Base Information

Drug NameTLC-144
Drug Alias NameTLC-144
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsCaspase inhibitors
TargetsCaspase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiwan Liposome Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiwan Liposome Company Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A